Temozolomide Capsule
Product Images NDC 65162-806

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 65162-806). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Temozolomide Capsules 1)

Chemical structure diagram of temozolomide, showing its heterocyclic ring system with nitrogen atoms and functional groups including an amide (CONH2) and a methyl group (CH3).*

FDA Label Image

10 (Temozolomide Capsules 10)

Packaging label for Temozolomide Capsules, USP, 140 mg strength. The label indicates oral capsules distributed by Amneal Pharmaceuticals LLC. The carton includes dosing information, storage instructions, and a warning not to open capsules due to cytotoxicity. The package design features the Amneal logo and a barcode, with space for lot number and expiration date.*

FDA Label Image

10 (Temozolomide Capsules 11)

Label for Temozolomide Capsules, USP 180 mg oral capsules by Amneal Pharmaceuticals LLC. The label includes NDC 65162-805-51 and states the capsules are cytotoxic, for oral administration, and prescription only. It instructs to read accompanying directions carefully and store at controlled room temperature. The package contains 5 capsules.*

FDA Label Image

10 (Temozolomide Capsules 12)

Packaging label for Temozolomide Capsules USP 180 mg, oral capsules distributed by Amneal Pharmaceuticals LLC. The label includes dosing caution, storage instructions, and a barcode. It indicates the product contains 5 capsules and emphasizes that the capsules should not be opened and must be swallowed whole due to cytotoxicity. The label features the Amneal logo and uses red, black, white, and green colors.*

FDA Label Image

10 (Temozolomide Capsules 13)

Label for Temozolomide Capsules, USP 250 mg by Amneal Pharmaceuticals LLC. The label specifies oral administration and cytotoxic nature, with a quantity of 5 capsules per package. It includes storage instructions between 20° to 25°C, barcode, and distributor information from Bridgewater, NJ.*

FDA Label Image

10 (Temozolomide Capsules 14)

Packaging label for Temozolomide Capsules USP 250 mg, oral capsule form. The label indicates the product is distributed by Amneal Pharmaceuticals LLC and includes usage warnings, storage instructions, and a barcode. The package contains 5 capsules and features a purple band with the Amneal logo at the bottom.*

FDA Label Image

1 (Temozolomide Capsules 2)

A survival curve graph titled 'ITT Population: Overall Survival' comparing two treatments: RT + TMZ and RT Only. The x-axis represents time from randomization in months, the y-axis shows probability. The chart includes a hazard ratio (HR) of 0.63 with a 95% confidence interval of 0.52-0.75 and a log-rank P-value less than 0.0001. The RT + TMZ line shows higher survival probability over time compared to RT Only.*

FDA Label Image

10 (Temozolomide Capsules 3)

Label for Temozolomide Capsules, USP 5 mg by Amneal Pharmaceuticals LLC. The label indicates oral administration, cytotoxic warning, and packaging of 5 capsules. Storage instructions and manufacturer information are also shown. The NDC number 65162-801-51 is visible along with a barcode.*

FDA Label Image

10 (Temozolomide Capsules 4)

Temozolomide Capsules, USP 5 mg oral capsules carton label from Amneal Pharmaceuticals LLC. The label shows the strength as 5 mg and indicates that the product is for oral administration. It includes a capsule image, directions to swallow whole, storage information, and a barcode. The label also warns about special dispensing information for pharmacists and cytotoxic handling precautions.*

FDA Label Image

10 (Temozolomide Capsules 5)

Label for Temozolomide Capsules, USP 20 mg, oral capsules containing 20 mg temozolomide. The label displays the NDC code 65162-802-51 and states it is for prescription use only with a 5-capsule count. Manufactured and distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. The label includes storage instructions and a caution about cytotoxicity.*

FDA Label Image

10 (Temozolomide Capsules 6)

Packaging label for Temozolomide Capsules, USP 20 mg by Amneal Pharmaceuticals LLC. The label indicates oral administration and the package contains 5 capsules. It includes safety instructions stating the capsules are cytotoxic and should not be opened but swallowed whole. Storage conditions specify 20° to 25°C with permitted excursions. The label features a barcode and Amneal logo at the bottom.*

FDA Label Image

10 (Temozolomide Capsules 7)

Label for Temozolomide Capsules USP 100 mg by Amneal Pharmaceuticals LLC. The oral capsule packaging contains 5 capsules. Instructions emphasize cytotoxic warning and advise reading accompanying directions. Storage conditions and dispensing information are included, along with a barcode and NDC 65162-803-51.*

FDA Label Image

10 (Temozolomide Capsules 8)

Temozolomide Capsules USP 100 mg oral capsules packaging label from Amneal Pharmaceuticals LLC. The label includes a warning that the capsules are cytotoxic and should not be opened, instructions for storage at controlled room temperature, and a barcode. The box is designed for 5 capsules and features the Amneal logo with a pink and white color scheme.*

FDA Label Image

10 (Temozolomide Capsules 9)

Temozolomide Capsules USP 140 mg oral capsules label by Amneal Pharmaceuticals LLC. The label includes dosage strength, storage instructions (20° to 25°C), cytotoxic warning, and directions to read accompanying information. It also notes packaging in tight containers and lists the distributor in Bridgewater, NJ. Barcode and NDC 65162-804-51 are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.